Trials / Completed
CompletedNCT00334711
Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
A Prospective Study of Sulfonylureas in Patients With Diabetes Due to Kir6.2 Mutations
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Royal Devon and Exeter NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether patients with diabetes due to Kir6.2 mutations can be treated with sulfonylurea medication rather than insulin, and if this is the case to investigate the mechanism for sulfonylurea response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sulfonylurea |
Timeline
- Start date
- 2004-01-01
- Completion
- 2006-01-01
- First posted
- 2006-06-08
- Last updated
- 2006-11-29
Source: ClinicalTrials.gov record NCT00334711. Inclusion in this directory is not an endorsement.